Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Saccaromyces Boulardii CNCM I-745 Supplementation on the Fecal Resistome of Patients Treated Against Helicobacter Pylori Infection

NCT04786938 is registered in ClinicalTrials.gov with Universidad San Francisco de Quito as lead sponsor.

NCT NCT04786938
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04786938 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Saccaromyces Boulardii CNCM I-745 Supplementation on the Fecal Resistome of Patients Treated Against Helicobacter Pylori Infection
Lead sponsor
Universidad San Francisco de Quito
Phase
Phase 4
Overall status
Completed
Start date
April 7, 2016
Completion date
June 9, 2017
Enrollment
72 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

gut resistome